AbbVie

Biogen gets go-ahead for EU Humira launch in October

https://pharmaphorum.com/customer-engagement/biogen-gets-go-ahead-eu-humira-launch-october/

AbbVie’s shares tank after cancer hopeful’s phase 2 setback

https://pharmaphorum.com/news/abbvie/

Pfizer eyes gastro use for Xeljanz after thumbs-up from FDA advisers

https://pharmaphorum.com/news/pfizer-eyes-gastro-use-xeljanz-thumbs-fda-advisers/

Lilly aims for new indication for Taltz

https://pharmaphorum.com/news/eli-lilly-aims-new-indication-il-17-drug-taltz/

NHS England plans to eliminate hep C by 2025 – with the help of pharma price cuts

https://pharmaphorum.com/news/englands-nhs-plans-eliminate-hep-c-2025/

Novartis files Humira biosimilar in US

https://pharmaphorum.com/news/sandoz-files-humira-biosimilar-us/

Novartis tests Cosentyx against Humira and biosimilars

https://pharmaphorum.com/news/novartis-tests-cosentyx-humira-biosimilars/

https://pharmaphorum.com/events/10th-risk-evaluation-mitigation-strategies-summit/

Roche/AbbVie drug could further improve prognosis in CLL

https://pharmaphorum.com/news/venetoclax-improve-prognosis-cll-doctor/

Close in 10 seconds

Pharmaphorum.com

Search